TREA

90980841 - ADC THERAPEUTICS

Follow

Information

  • Trademark
  • 90980841
  • Serial Number
    90980841
  • Registration Number
    7367665
  • Filing Date
    November 05, 2020
    3 years ago
  • Registration Date
    April 23, 2024
    a month ago
  • Transaction Date
    April 30, 2024
    a month ago
  • Status Date
    April 23, 2024
    a month ago
  • Published for Opposition Date
    May 24, 2022
    2 years ago
  • Location Date
    March 19, 2024
    2 months ago
  • First Use Anywhere Date
    May 03, 2021
    3 years ago
  • First Use In Commerce Date
    May 03, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    EULIN, INGRID C
  • Attorney Docket Number
    3309.0330001
    Attorney Name
    TRACY-GENE G. DURKIN
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
5
Mark Identification
ADC THERAPEUTICS
Case File Statements
  • DM0000: The mark consists of the letters "ADC" above the word "THERAPEUTICS". The letters "ADC" are in darker and lighter shades of blue. An orange wave element extends across the letter "A" to a shared edge of the letters "D" and "C". The word "THERAPEUTICS" is orange.
  • GS0051: Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for use in the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, pharmaceutical antibodies; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of oncological diseases, disorders, and conditions; pharmaceutical preparations for the treatment of oncological diseases, disorders, and conditions; biological preparations for the treatment of oncological diseases, and conditions
  • CC0000: The color(s) blue and orange is/are claimed as a feature of the mark.
  • GS0441: Providing medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, and health
  • DS0000: "THERAPEUTICS"
  • GS0421: Pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals
Case File Event Statements
  • 11/9/2020 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/6/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/2/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/6/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/6/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/6/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/5/2021 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/5/2021 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/6/2021 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/6/2021 - 2 years ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 10/6/2021 - 2 years ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 10/6/2021 - 2 years ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 4/6/2022 - 2 years ago
    13 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 4/6/2022 - 2 years ago
    14 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 4/6/2022 - 2 years ago
    15 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 4/6/2022 - 2 years ago
    16 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 4/7/2022 - 2 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 4/12/2022 - 2 years ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 4/13/2022 - 2 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/13/2022 - 2 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/20/2022 - 2 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/20/2022 - 2 years ago
    22 - EXPARTE APPEAL TERMINATED Type: EXPT
  • 5/4/2022 - 2 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/24/2022 - 2 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/24/2022 - 2 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/19/2022 - a year ago
    26 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/18/2023 - a year ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/18/2023 - a year ago
    28 - SOU EXTENSION 1 FILED Type: EXT1
  • 1/18/2023 - a year ago
    29 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 1/20/2023 - a year ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/13/2023 - 10 months ago
    31 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/13/2023 - 10 months ago
    32 - SOU EXTENSION 2 FILED Type: EXT2
  • 7/13/2023 - 10 months ago
    33 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 7/15/2023 - 10 months ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/18/2024 - 4 months ago
    38 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 1/18/2024 - 4 months ago
    40 - USE AMENDMENT FILED Type: IUAF
  • 1/18/2024 - 4 months ago
    35 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 1/18/2024 - 4 months ago
    36 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 2/5/2024 - 3 months ago
    37 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 2/26/2024 - 3 months ago
    39 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 2/26/2024 - 3 months ago
    41 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 3/19/2024 - 2 months ago
    42 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 3/20/2024 - 2 months ago
    43 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 4/23/2024 - a month ago
    44 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/23/2024 - a month ago
    45 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC